A highly innovative technology that determines the efficiency of molecules and rapidly evaluates their innocuity
The ability to evaluate potential molecules of interest quickly and efficiently obtained from high throughput screening is an essential element of modern R&D programmes. However up until now, once a potential molecule of interest has been discovered, it is essential to carry out tests on animals - a process which is fraught with legal, technical and ethical issues as well as being time consuming.
This innovative in ovo screening technology enables healthcare professionals to avoid the pitfalls associated with animal testing by using a process that is both fast and efficient. In ovo screening, covering embryonic toxicology, angiogenesis, and tumor growth is a radical new means of speeding up the process of evaluating new molecules of interest; before carrying out pre-clinical testing on animals.
Furthermore, the efficiency of this process ensures that the screening process is optimised; with all low-value molecules being eliminated from the study at a very early stage.
In Ovo screening : assessment of electromagnetic radiation
An Innovative technology that enables the fast and efficient evaluation of the impact of electromagnetic waves on embryonic development
Introduction
The ability to quickly and efficiently evaluate the effect of intense, long-term electromagnetic exposure on humans and on embryonic development is a key requirement in public healthcare.
In ovo screening is an innovative technology that provides a solution to this problem: via an analytical model that works on both macroscopic and molecular levels.
The in ovo model enables a clear understanding of the possible effects of electromagnetic exposure on humans as well as reducing the need to carry out scientific experiments on animals.
In Ovo Screening : valuable Rerearch and Development Tool
A valuable research and development tool
In OVO testing process (on avian embryos): a fast, efficient and practical means of evaluating the inocuity/toxicity of chemical and environmental compounds (process is exempt from legislation concerning animal testing)
Introduction
The ability to quickly and efficiently evaluate the effect of chemical and environmental compounds on living organisms and to predict their impact at an early stage can prove a challenge with regards to the management of public health and the environment. In ovo screening(amniotic model), is an innovative technology that provides a solution to this problem through a process that enables testing to be first carried out on bird embryos.
Embryonic toxicity when first tested on bird embryos both enables a clear understanding of possible effects on humans as well as reducing the number of tests that need to be carried out on animals. In ovo screening can prove to be highly beneficial in R&D programmes where the key objective is the identification of new molecules.
